Sinopep-Allsino
688076.SSSinopep-Allsino Bio Pharmaceutical Co.,Ltd. Price (688076.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
214,389,612
(0.5656)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers formulations, such as thymalfasin products for injection, eptifibatide injections, alogliptin benzoate tablets, and oseltamivir phosphate capsules; APIs and intermediates; and drugs for type 2 diabetes and obesity, and coronavirus. It also provides pharmaceutical research, clinical, and registration services of drugs; and undertakes CDMO/CMO pr... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $47.48-81.5
- Market Cap 12.96B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Mr. Wei Ding
- IPO Date: May, 20, 2021
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 1545
- Revenue from each product or segment:
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|
- Revenue by Region
| Product or Segment | Value: | % - Total | Last 3Y: |
|---|